SCHEMBL7227202

SCHEMBL7227202

C[C@]1(C(=O)O)COCN1S(=O)(=O)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 6/20 0.39
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ITGB1 P05556 6/20 0.35
ITGA4 P13612 6/20 0.35
ACLY P53396 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SLC13A5 Q86YT5 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
ITGB7 P26010 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7227210 1.00 CNR1 (0.39) CNR1MEN1KMT2AITGB1ITGA4
SCHEMBL7227199 1.00 CNR1 (0.39) CNR1MEN1KMT2AITGB1ITGA4
SCHEMBL7227630 0.79 KMT2A (0.45) CNR1MEN1KMT2AITGB1ITGA4
SCHEMBL7227628 0.79 KMT2A (0.45) CNR1MEN1KMT2AITGB1ITGA4
SCHEMBL7227633 0.79 KMT2A (0.45) CNR1MEN1KMT2AITGB1ITGA4
SCHEMBL21519754 0.77 ITGB1 (0.49) CNR1MEN1KMT2AITGB1ITGA4
SCHEMBL5201121 0.77 ITGB1 (0.49) CNR1MEN1KMT2AITGB1ITGA4
SCHEMBL5201582 0.75 CNR1 (0.41) CNR1MEN1KMT2AITGB1ITGA4
SCHEMBL5200881 0.75 CNR1 (0.41) CNR1MEN1KMT2AITGB1ITGA4
SCHEMBL5201586 0.75 CNR1 (0.41) CNR1MEN1KMT2AITGB1ITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645939-B1 Very late antigen-4 (VLA) integrin antagonists; antiallergens, antiasthmatics, and antiinflammatory agents; multiple sclerosis, autoimmune disease treatment MERCK & CO., INC. 2003-11-11 US disclosed